SURF — Surface Oncology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $65.08m
- $8.82m
- $30.00m
Annual cashflow statement for Surface Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.6 | -54.8 | 59.3 | -78.5 | -63.6 |
| Depreciation | |||||
| Non-Cash Items | 4.85 | 7.12 | 11.3 | 12.5 | 10.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.8 | -14.3 | -42.3 | 2.11 | -7.59 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.2 | -60.1 | 30 | -62.3 | -59.6 |
| Capital Expenditures | -2.02 | -1.54 | -0.043 | -0.12 | -0.497 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -34.6 | 18.5 | 58.4 | -99.1 | 23.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -36.6 | 17 | 58.3 | -99.3 | 22.8 |
| Financing Cash Flow Items | 9.47 | — | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 110 | 7.42 | 40.1 | 42.5 | 31.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 60.6 | -35.8 | 128 | -119 | -5.13 |